These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9815916)

  • 1. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
    Xu Y; Gaudette DC; Boynton JD; Frankel A; Fang XJ; Sharma A; Hurteau J; Casey G; Goodbody A; Mellors A
    Clin Cancer Res; 1995 Oct; 1(10):1223-32. PubMed ID: 9815916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
    Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
    Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lysophospholipids on signaling in the human Jurkat T cell line.
    Xu Y; Casey G; Mills GB
    J Cell Physiol; 1995 Jun; 163(3):441-50. PubMed ID: 7775587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
    Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
    Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.
    Shen Z; Wu M; Elson P; Kennedy AW; Belinson J; Casey G; Xu Y
    Gynecol Oncol; 2001 Oct; 83(1):25-30. PubMed ID: 11585410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells.
    Shen Z; Belinson J; Morton RE; Xu Y; Xu Y
    Gynecol Oncol; 1998 Dec; 71(3):364-8. PubMed ID: 9887232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lysophospholipase D activity by unsaturated lysophosphatidic acids or seed extracts containing 1-linoleoyl and 1-oleoyl lysophosphatidic acid.
    Liu XW; Sok DE; Yook HS; Sohn CB; Chung YJ; Kim MR
    J Agric Food Chem; 2007 Oct; 55(21):8717-22. PubMed ID: 17887800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
    Sandmann G; Siess W; Essler M
    Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid-depleted serum, hepatocyte growth factor and stem cell growth factor stimulate colony growth of small cell lung cancer cells through a calcium-independent pathway.
    Seckl MJ; Seufferlein T; Rozengurt E
    Cancer Res; 1994 Dec; 54(23):6143-7. PubMed ID: 7525056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
    Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.
    Furui T; LaPushin R; Mao M; Khan H; Watt SR; Watt MA; Lu Y; Fang X; Tsutsui S; Siddik ZH; Bast RC; Mills GB
    Clin Cancer Res; 1999 Dec; 5(12):4308-18. PubMed ID: 10632375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action.
    Mills GB; May C; McGill M; Roifman CM; Mellors A
    Cancer Res; 1988 Mar; 48(5):1066-71. PubMed ID: 3422589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lysophosphatidylglycerol on several signaling molecules in OVCAR-3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.
    Park KS; Kim MK; Im DS; Bae YS
    Biochem Pharmacol; 2007 Mar; 73(5):675-81. PubMed ID: 17161826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
    Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
    Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells.
    Frankel A; Mills GB
    Clin Cancer Res; 1996 Aug; 2(8):1307-13. PubMed ID: 9816301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a lysophosphatidic acid receptor.
    Thomson FJ; Perkins L; Ahern D; Clark M
    Mol Pharmacol; 1994 Apr; 45(4):718-23. PubMed ID: 8183251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophospholipids activate ovarian and breast cancer cells.
    Xu Y; Fang XJ; Casey G; Mills GB
    Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):933-40. PubMed ID: 7639713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.
    Qian L; Xu Y; Arai H; Aoki J; McIntyre TM; Prestwich GD
    Org Lett; 2003 Nov; 5(24):4685-8. PubMed ID: 14627415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.
    Park KS; Lee HY; Lee SY; Kim MK; Kim SD; Kim JM; Yun J; Im DS; Bae YS
    FEBS Lett; 2007 Sep; 581(23):4411-6. PubMed ID: 17719584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma.
    Elg SA; Mayer AR; Carson LF; Twiggs LB; Hill RB; Ramakrishnan S
    Cancer; 1997 Oct; 80(8):1448-56. PubMed ID: 9338469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.